In addition, CrD-SBC patients with co-expression of MUC5AC and CK7 by the cancer (15 cases) featured a worse prognosis in comparison with those negative for both markers (17 cases) or with expression of either MUC5AC or CK7 (20 cases) (Fig. 3c). This evidence concerns the gene MUC5AC and cancer.